BY AND BETWEENPurchase and Sale Agreement • May 12th, 1998 • Procyte Corp /Wa/ • Pharmaceutical preparations • Washington
BY AND BETWEENEmployment Agreement • May 12th, 1998 • Procyte Corp /Wa/ • Pharmaceutical preparations • Washington
RECITALS: ---------Asset Purchase Agreement • August 2nd, 2001 • Procyte Corp /Wa/ • Pharmaceutical preparations • Washington
INDEMNITY AGREEMENT between TYPE IN EXECUTIVE NAME andIndemnity Agreement • August 12th, 1998 • Procyte Corp /Wa/ • Pharmaceutical preparations • Washington
EXHIBIT 4.1Rights Agreement • May 28th, 1998 • Procyte Corp /Wa/ • Pharmaceutical preparations • Washington
EXHIBIT 10.3 CHANGE OF CONTROL AGREEMENTChange of Control Agreement • August 12th, 1998 • Procyte Corp /Wa/ • Pharmaceutical preparations
BY AND BETWEENEmployment Agreement • May 12th, 1998 • Procyte Corp /Wa/ • Pharmaceutical preparations • Washington
EXHIBIT 10.18 CONSULTING AGREEMENT This Consulting Agreement is entered into as of June 1, 1999 between ProCyte Corporation, a Washington corporation, hereinafter referred to as the "Company" and Glenn Oclassen, hereinafter referred to as the...Consulting Agreement • August 13th, 1999 • Procyte Corp /Wa/ • Pharmaceutical preparations • Washington
Redacted Version LICENSE AGREEMENT ----------------- This Agreement is by and between ProCyte Corporation, having an address at 8511-154th Avenue N.E., Redmond, Washington 98052 (hereinafter referred to as "PROCYTE") and Neutrogena Corporation, having...License Agreement • May 3rd, 2000 • Procyte Corp /Wa/ • Pharmaceutical preparations • New York
EXHIBIT 10.6 AGREEMENT BETWEEN HYMEDIX INTERNATIONAL, INC. AND PROCYTE CORPORATIONStock Acquisition Agreement • March 25th, 1996 • Procyte Corp /Wa/ • Pharmaceutical preparations • Washington
CHANGE OF CONTROL AGREEMENTChange of Control Agreement • August 12th, 2004 • Procyte Corp /Wa/ • Pharmaceutical preparations
This Change of Control Agreement (this “Agreement”), dated as of July 1, 2004, is between PROCYTE CORPORATION, a Washington corporation (the “Company”), and JOHN F. CLIFFORD (the “Executive”).
EXHIBIT 10.2 CHANGE OF CONTROL AGREEMENT betweenChange of Control Agreement • August 12th, 1998 • Procyte Corp /Wa/ • Pharmaceutical preparations
AGREEMENT AND PLAN OF MERGER by and amongAgreement and Plan of Merger • December 6th, 2004 • Procyte Corp /Wa/ • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER (the “Agreement”) is entered into as of December 1, 2004, by and among PhotoMedex, Inc., a Delaware corporation (“Buyer”), Gold Acquisition Corp., a Washington corporation (“Merger Sub”), and a direct wholly-owned subsidiary of Buyer, and ProCyte Corporation, a Washington corporation (“Company”).
FIFTH AMENDMENT TO LEASETo Lease • October 28th, 2004 • Procyte Corp /Wa/ • Pharmaceutical preparations
This FIFTH AMENDMENT TO LEASE (this “Fifth Amendment”) is made this 20th day of October, 2004, by and between TIAA REALTY, INC., a Delaware corporation (“Landlord”) and PROCYTE CORPORATION, a Washington corporation (“Tenant”).
RECITALSEmployment and Separation Agreement • March 31st, 1998 • Procyte Corp /Wa/ • Pharmaceutical preparations
INDEMNITY AGREEMENTIndemnity Agreement • August 20th, 2004 • Procyte Corp /Wa/ • Pharmaceutical preparations • Washington
THIS INDEMNITY AGREEMENT (this “Agreement”) is made by and between PROCYTE CORPORATION, a Washington corporation (the “Company”), and ROBERT W. BENSON (the “Indemnitee”), as of June 3, 2004.
QuickLinks -- Click here to rapidly navigate through this documentRights Agreement • December 6th, 2004 • Procyte Corp /Wa/ • Pharmaceutical preparations
Subject to the terms hereof, pursuant to Section 26 of the Rights Agreement, dated as of December 7, 1994, by and between ProCyte Corporation (the "Company") and Computershare Investor Services (formerly, American Securities Transfer, Inc.) (the "Rights Agreement"), the Company, by this Amendment of Rights Agreement dated as of December 1, 2004, does hereby amend the Rights Agreement as follows:
PROCYTE CORPORATION KEY EXECUTIVE SEVERANCE AGREEMENTProcyte Corporation Key Executive Severance Agreement • August 12th, 2004 • Procyte Corp /Wa/ • Pharmaceutical preparations
This Key Executive Severance Agreement (this “Agreement”), dated and effective as of July 1, 2004, is between PROCYTE CORPORATION, a Washington corporation (the “Company”), and JOHN F. CLIFFORD (the “Executive”).
ASSET PURCHASE AGREEMENT by and among ProCyte Corporation as Seller and ICOS Corporation as Purchaser and AMT Capital, Ltd., solely for the purpose of Section 3.5(b)Asset Purchase Agreement • October 28th, 2004 • Procyte Corp /Wa/ • Pharmaceutical preparations • Washington
THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of the 22nd day of October, 2004, by and among ProCyte Corporation, a Washington corporation (“Seller”), AMT Capital, Ltd., a Texas limited partnership (“AMT”), solely for the purpose of Section 3.5(b), and ICOS Corporation, a Delaware corporation (“Purchaser”).
STOCKHOLDER AGREEMENTStockholder Agreement • December 6th, 2004 • Procyte Corp /Wa/ • Pharmaceutical preparations • Delaware
THIS STOCKHOLDER AGREEMENT (the “Agreement”) is entered into as of December 1, 2004, by and among PhotoMedex, Inc, a Delaware corporation (“Buyer”), Gold Acquisition Corp., Inc., a Washington corporation and wholly owned subsidiary of Buyer (“Merger Sub”), and the undersigned stockholder (“Stockholder”) of ProCyte Corporation, a Washington corporation (“Company”).
RECITALSConsulting and Separation Agreement • November 14th, 1996 • Procyte Corp /Wa/ • Pharmaceutical preparations
